Outcomes
TG
SECONDARY
Given routine clinical practice and the time required to achieve maximal lipid reduction, the follow-up period was designed to be 6 months from the start of lipid-lowering medication, which was concurrent with the CBT intervention. The study’s primary outcome was the change in the LDL-C level from enrollment to each follow-up node. The secondary outcomes were TG, C-reactive protein (CRP), the score of GSE, and the QL-index.